AlumiFuel Power, Inc. Provides Update on Its Flameless Ration Heater Initiatives

Early production stage hydrogen generation company AlumiFuel Power, Inc. (“API”), the Philadelphia, Pennsylvania-based wholly owned operating subsidiary of AlumiFuel Power Corporation (OTCBB: AFPW), (the “Company”), announced today that it is continuing to make progress in penetrating the $70 million worldwide market for Flameless Ration Heaters (FRHs) for military and commercial markets. (See API news releases of January 4, 2010 and December 22, 2009)

API has now completed the next level of testing of its Flameless Ration Heater (FRH) product. In addition to exceeding the heat output of the existing FRH, the API product does not have the metallic smell of the present magnesium powder-based FRHs, which represent a $36 million annual market for the U.S. military. API has presented its product concept and test results to key personnel in the Department of Defense, and is actively working with them to qualify API as a subcontractor to the three Meals-Ready-to-Eat (MRE) assemblers now supplying the U.S. military market.

In addition to further optimizing its powder mixture for FRH applications, API and its world class packaging partner, ActionPak (see API news release of February 19, 2010), have begun to develop the most cost effective production packaging configuration for the FRH. The two companies are jointly working to develop a novel packaging method that will increase the product’s performance, decrease cost, and be environmentally friendly.

In addition to developing the FRH for domestic military and civilian markets, API is positioning itself to introduce the product overseas. NATO countries use approximately $20 million worth of products equivalent to MREs annually. These meals either feature no heating system or use a hexamine tablet for heating, an expensive method requiring an open flame, which releases potentially dangerous gases such as cyanides and carbon monoxide, and leaves a sticky residue.

Military units in NATO countries have become familiar with U.S. military MREs/FRHs, and have been seeking independent sources of these products directly from distributors. This has caused NATO Ministries of Defense to consider adopting the U.S.-type MRE/FRH technology/products on a contractual basis. As a result of this growing interest, API and ActionPak are exploring specific near-term FRH procurement opportunities in Europe.

API’s Director of Engineering, Mr. Sean McIntosh, said “We are looking forward to commercializing this product on a worldwide scale. Heat generation is a very important part of API’s technology, and the knowledge that we have gained during the development of this FRH will be useful in the development of related products such as personal handwarmers.”

About AlumiFuel Power, Inc.
API is an early production stage alternative energy company that generates hydrogen gas and superheated steam through the chemical reaction of aluminum, water, and proprietary additives. This technology is ideally suited for multiple niche applications requiring on-site, on-demand fuel sources, serving National Security and commercial customers. API’s hydrogen feeds fuel cells for portable and back-up power, fills inflatable devices such as weather balloons, and can replace costly, hard-to-handle and high pressure K-Cylinders. Its hydrogen/heat output is also being designed and developed to drive turbine-based underwater propulsion systems and auxiliary power systems, and as the fuel for Flameless Ration Heaters. API has significant differentiators in performance, adaptability, safety and cost-effectiveness in its target market applications, with no external power required and no toxic chemicals or by-products.

About AlumiFuel Power Corporation
AlumiFuel Power Corporation, formerly known as Inhibiton Therapeutics, Inc., recently acquired its wholly-owned operating subsidiary AlumiFuel Power, Inc., a Philadelphia-based early production stage alternative energy company that generates hydrogen gas and steam for multiple niche applications requiring on-site, on-demand fuel sources. The Company also has been conducting biotechnology research, development and potential commercialization of technologies and products for new cancer therapeutic agents and cancer fighting drugs called targeted therapies.

Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, they are based on management’s current beliefs and assumptions as to future events. However, since the company’s operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission.

Source: Business Wire/Yahoo Finance